美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 12 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| SUCRALFATE |
070848 |
001 |
ANDA |
SUCRALFATE |
TABLET;ORAL |
1GM |
No
|
No
|
1996/03/29
|
1996/03/29
|
TEVA |
Prescription |
| SUCRALFATE |
074415 |
001 |
ANDA |
SUCRALFATE |
TABLET;ORAL |
1GM |
No
|
No
|
1998/06/08
|
1998/06/08
|
NOSTRUM LABS INC |
Prescription |
| SUCRALFATE |
209356 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2019/12/02
|
2019/12/02
|
AMNEAL |
Prescription |
| SUCRALFATE |
211884 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2022/03/15
|
2022/03/15
|
VISTAPHARM LLC |
Prescription |
| SUCRALFATE |
215576 |
001 |
ANDA |
SUCRALFATE |
TABLET;ORAL |
1GM |
No
|
No
|
2022/04/15
|
2022/04/15
|
AMNEAL PHARMS |
Prescription |
| SUCRALFATE |
212913 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2022/09/12
|
2022/09/12
|
MYLAN |
Prescription |
| SUCRALFATE |
215705 |
001 |
ANDA |
SUCRALFATE |
TABLET;ORAL |
1GM |
No
|
No
|
2023/05/03
|
2023/05/03
|
ZYDUS LIFESCIENCES |
Prescription |
| SUCRALFATE |
213549 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2024/01/17
|
2024/01/17
|
PD PARTNERS |
Prescription |
| SUCRALFATE |
216726 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2024/03/21
|
2024/03/21
|
ABON PHARMS LLC |
Prescription |
| SUCRALFATE |
216474 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2024/05/21
|
2024/05/21
|
STRIDES PHARMA |
Prescription |
| SUCRALFATE |
212769 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2024/07/23
|
2024/07/23
|
HIKMA |
Prescription |
| SUCRALFATE |
217126 |
001 |
ANDA |
SUCRALFATE |
SUSPENSION;ORAL |
1GM/10ML |
No
|
No
|
2024/11/13
|
2024/11/13
|
COSETTE |
Prescription |